Financhill
Sell
46

NAMS Quote, Financials, Valuation and Earnings

Last price:
$25.50
Seasonality move :
43.24%
Day range:
$24.55 - $26.25
52-week range:
$10.50 - $27.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
68.38x
P/B ratio:
6.22x
Volume:
1M
Avg. volume:
1.2M
1-year change:
142.86%
Market cap:
$2.4B
Revenue:
$14.1M
EPS (TTM):
-$2.25

Earnings Data

Next earnings date for NAMS
Feb 28
2025
Most recent earnings per share
-$0.18
Beat by $0.31
(Nov 6/2024)
Consensus Estimate
-$0.49
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NAMS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $1.7M -- -- -$0.50 --
11/06/2024 Q3 $1.8M $29.1M -$0.18 -$0.49 $0.31
08/07/2024 Q2 $1.2M $2.3M -$0.41 -$0.57 $0.16
05/09/2024 Q1 $1.7M $1.4M -$1.06 -$0.52 -$0.54
02/28/2024 Q4 $1.9M $803K -$0.60 -$0.59 -$0.01
11/13/2023 Q3 -- -- -- -$0.52 --
08/07/2023 Q2 -- -- -$0.49 -$0.47 -$0.02
05/08/2023 Q1 -- -- -$0.51 -- --
12/31/2022 Q4 -- -- -- -$0.43 --
09/30/2022 Q3 -- -- -- -$0.59 --

NewAmsterdam Pharma Co NV Earnings Questions

  • How Much did NewAmsterdam Pharma Co NV Generate in Revenue Last Quarter?

    NewAmsterdam Pharma Co NV reported $29.1M worth of top line sales in its most recent quarter.

  • Did NewAmsterdam Pharma Co NV Beat Earnings Last Quarter?

    NewAmsterdam Pharma Co NV announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.49 per share.

  • Is NewAmsterdam Pharma Co NV Profitable?

    NewAmsterdam Pharma Co NV reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for NewAmsterdam Pharma Co NV EPS Next Year?

    NewAmsterdam Pharma Co NV's earnings are forecast to decrease from -$2.15 per share to -$2.19 per share next year representing a decrease of -2.34%.

  • When is NewAmsterdam Pharma Co NV's Earnings Date?

    NewAmsterdam Pharma Co NV's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock